Delivery Order SPE2DR25D1103-SPE2DR26FE241
- Not listed
- The Defense Logistics Agency awarded a $4,852.12 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $4,828.41 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL doses. This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $4,531.80 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of July 31, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $10,434.52 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. The contract, designated as a firm fixed-price delivery order, was competitively awarded with no set-aside provisions and carries an ultimate completion date of December 4, 2025. AmerisourceBergen will perform the work from its corporate headquarters in Conshohocken, Pennsylvania. This award is a child order issued under...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,657.29 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL of pharmaceutical product. The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order issued under a larger contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,979.90 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) pen 40 mg/0.4 mL units, with an ultimate completion date of December 1, 2025. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,063.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a $6,405.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 ml dosage. This is a non-set-aside, competitively awarded contract with a completion date of September 29, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, due for completion by June 2, 2025. The award was issued on May 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE241Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,132.38 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 8, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its larger indefinite delivery contract with DLA Troop Support Medical. This delivery order is a child contract under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 indefinite delivery vehicle with the Defense Logistics Agency (designated SPE2DX), which extends through December 2026 and enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The pharmaceutical prime vendor arrangement allows the contractor to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a broad range of medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/4/25 |